GT Biopharma Inc (GTBP) — Cash Flow Quality Index
GT Biopharma Inc (GTBP) has a Cash Flow Quality Index of -0.69x as of June 2016. Operating cash flow of $-1.06 Million is below net income of $1.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore GTBP cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GT Biopharma Inc Cash Flow Quality Index (1987–2016)
Historical Cash Flow Quality Index for GT Biopharma Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of GT Biopharma Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GT Biopharma Inc (1987–2016)
Year-by-year earnings quality comparison for GT Biopharma Inc. For live market cap and the full company financial profile, see GTBP market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | -0.09x | $-1.93 Million | $21.03 Million | ▲ +90.5% |
| 2007 | -0.96x | $-270.00K | $280.00K | ▼ -196.4% |
| 1990 | 1.00x | $900.00K | $900.00K | ▲ +0.0% |
| 1989 | 1.00x | $700.00K | $700.00K | ▲ +0.0% |
| 1988 | 1.00x | $100.00K | $100.00K | ▲ +500.0% |
| 1987 | 0.17x | $50.00K | $300.00K | — |